Pages that link to "Q28116222"
Jump to navigation
Jump to search
The following pages link to A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth (Q28116222):
Displaying 50 items.
- androgen receptor (Q416601) (← links)
- Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival (Q21091046) (← links)
- Androgen receptor variants occur frequently in castration resistant prostate cancer metastases (Q21558502) (← links)
- Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor (Q24319189) (← links)
- Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer (Q26739708) (← links)
- Splice Variants of Androgen Receptor and Prostate Cancer (Q26740592) (← links)
- Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer (Q26742062) (← links)
- Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting (Q26745907) (← links)
- A sting in the tail: the N-terminal domain of the androgen receptor as a drug target (Q26747094) (← links)
- Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice (Q26748538) (← links)
- Clonal origin and spread of metastatic prostate cancer (Q26752873) (← links)
- Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics (Q26773613) (← links)
- Mechanisms of resistance in castration-resistant prostate cancer (CRPC) (Q26774221) (← links)
- Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism (Q26774456) (← links)
- Persistent androgen receptor addiction in castration-resistant prostate cancer (Q26777163) (← links)
- Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer (Q26777310) (← links)
- Unveiling the potential of prohibitin in cancer (Q26785744) (← links)
- Targeting molecular resistance in castration-resistant prostate cancer (Q26795445) (← links)
- Insights into Chemoresistance of Prostate Cancer (Q26795589) (← links)
- Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies (Q26796704) (← links)
- Androgen receptor footprint on the way to prostate cancer progression (Q26825402) (← links)
- Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer (Q26852582) (← links)
- Abiraterone in the treatment of metastatic castration-resistant prostate cancer (Q26853635) (← links)
- Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer (Q26858922) (← links)
- Androgen receptor on the move: boarding the microtubule expressway to the nucleus (Q26862560) (← links)
- Potential molecular targeting of splice variants for cancer treatment (Q27008529) (← links)
- Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression (Q27022288) (← links)
- Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells (Q27335252) (← links)
- AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer (Q27853062) (← links)
- Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer (Q28067556) (← links)
- The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance (Q28076745) (← links)
- Emerging data on androgen receptor splice variants in prostate cancer (Q28077830) (← links)
- Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer (Q28487695) (← links)
- Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells (Q28539233) (← links)
- Hormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the knee (Q28706277) (← links)
- Cistrome plasticity and mechanisms of cistrome reprogramming (Q28727255) (← links)
- High throughput microscopy identifies bisphenol AP, a bisphenol A analog, as a novel AR down-regulator (Q28830542) (← links)
- Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant (Q30495758) (← links)
- Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells (Q30500293) (← links)
- AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression (Q30513836) (← links)
- 20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor. (Q30528764) (← links)
- AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancer (Q30544584) (← links)
- TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer. (Q30554439) (← links)
- Targeted androgen pathway suppression in localized prostate cancer: a pilot study (Q30563985) (← links)
- Androgen receptor splice variants determine taxane sensitivity in prostate cancer (Q30577613) (← links)
- The link between androgen receptor splice variants and castration-resistant prostate cancer (Q30618562) (← links)
- Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer. (Q30831010) (← links)
- Getting Personal with Prostate Cancer: Adding New Pieces to an Incomplete Jigsaw Puzzle (Q33351113) (← links)
- Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation (Q33390573) (← links)
- Androgen receptor splice variants and prostate cancer: From bench to bedside (Q33567024) (← links)